2022
DOI: 10.3390/medicina58060732
|View full text |Cite
|
Sign up to set email alerts
|

Cervical Cancer Prevention in the Era of the COVID-19 Pandemic

Abstract: Background and Objectives: Cervical cancer (CC) is the fourth most common cause of cancer-related morbidity and mortality among women worldwide. CC prevention is based on screening and HPV vaccination. The COVID-19 pandemic has caused difficulties in implementing CC-preventative measures. The aim of this study was to collect data on the implementation of CC prophylaxis in Poland provided by public and private health care with a particular focus on the impact of the COVID-19 pandemic and attempt to estimate the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
1
0
3

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 57 publications
0
1
0
3
Order By: Relevance
“…Contudo, os exames de CO não foram totalmente interrompidos, visto que, segundo a literatura, as pacientes que já apresentavam lesão com malignidade não tiveram o atendimento afetado (Sasidharanpillai & Ravishankar, 2022), portanto, apesar da diminuição dos exames, ainda houve seguimento dessas pacientes. Entretanto, a redução do rastreio é um fator predisponente para o aumento de lesões pré-malignas sem diagnóstico precoce, prejudicando o tratamento e o prognóstico dessas pacientes (Poniewierza & Panek, 2022). Somado a isso, apesar do retorno gradual da realização da CO, devido à demora no que concerne ao seu resultado e à persistência do medo de se expor à infecção pelo SARS-CoV-2, houve baixa procura das mulheres ao exame durante a pandemia (Costa et al, 2021).…”
Section: Fonte: Autores (2022)unclassified
“…Contudo, os exames de CO não foram totalmente interrompidos, visto que, segundo a literatura, as pacientes que já apresentavam lesão com malignidade não tiveram o atendimento afetado (Sasidharanpillai & Ravishankar, 2022), portanto, apesar da diminuição dos exames, ainda houve seguimento dessas pacientes. Entretanto, a redução do rastreio é um fator predisponente para o aumento de lesões pré-malignas sem diagnóstico precoce, prejudicando o tratamento e o prognóstico dessas pacientes (Poniewierza & Panek, 2022). Somado a isso, apesar do retorno gradual da realização da CO, devido à demora no que concerne ao seu resultado e à persistência do medo de se expor à infecção pelo SARS-CoV-2, houve baixa procura das mulheres ao exame durante a pandemia (Costa et al, 2021).…”
Section: Fonte: Autores (2022)unclassified
“…Odnaleziono 4 badania oceniające wpływ pandemii COVID-19 na poziom realizacji świadczeń zdrowotnych dotyczących programów profilaktycznych lub badań kontrolnych [24][25][26][27]. Wszystkie te prace miały zasięg ogólnopolski.…”
Section: Programy Profilaktyczne I Badania Kontrolneunclassified
“…W przypadku wszystkich ocenianych programów profilaktycznych wykazano negatywny wpływ pandemii COVID-19 na poziom realizacji świadczeń co najmniej w wybranych okresach obserwacji lub dla wybranych obszarów systemu. W przypadku programu profilaktyki raka szyjki macicy stwierdzono, że w okresie pandemii liczba badań skriningowych znacznie się zmniejszyła (spadki obserwowane były również w latach wcześniejszych), jednak tylko w placówkach finansowanych przez NFZ [24]. W przypadku programu powszechnych przesiewowych badań słuchu u noworodków w 2020 roku doszło do znacznego pogorszenia dostępu do świadczeń ze względu na czasowe zawieszenie działalności 67% ośrodków prowadzących diagnostykę audiologiczną oraz funkcjonowanie pozostałych placówek w szczególnym reżimie sanitarno-epidemiologicznym.…”
Section: Programy Profilaktyczne I Badania Kontrolneunclassified
“…Cervical cancer (CC) ranks as the fourth most common cancer among women and is a leading cause of cancer-specific mortality among women worldwide ( Rahangdale et al, 2022 , Ran et al, 2022 ). In 2020, 604,000 new CC cases were diagnosed, and resulted in 342,000 deaths in women globally ( Poniewierza and Panek, 2022 ). After treatment, the survival rate of CC patients is significantly increased ( Siegel et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%